ArticleBMJ open2025

Tirzepatide for fertility-sparing treatment in obese/overweight patients with endometrial cancer and atypical hyperplasia: a phase II single-arm clinical trial protocol.

Jing Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.